BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8117304)

  • 1. The non-peptide tachykinin NK2 receptor antagonist SR 48968 interacts with human, but not rat, cloned tachykinin NK3 receptors.
    Chung FZ; Wu LH; Vartanian MA; Watling KJ; Guard S; Woodruff GN; Oxender DL
    Biochem Biophys Res Commun; 1994 Feb; 198(3):967-72. PubMed ID: 8117304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of [125I][MePhe7]neurokinin B binding to tachykinin NK3 receptors: evidence for interspecies variance.
    Suman-Chauhan N; Grimson P; Guard S; Madden Z; Chung FZ; Watling K; Pinnock R; Woodruff G
    Eur J Pharmacol; 1994 Sep; 269(1):65-72. PubMed ID: 7530207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
    Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
    Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of NK3 receptors in rabbit isolated iris sphincter muscle.
    Medhurst AD; Parsons AA; Roberts JC; Hay DW
    Br J Pharmacol; 1997 Jan; 120(1):93-101. PubMed ID: 9117105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of methionine134 and alanine146 in the second transmembrane segment of the human tachykinin NK3 receptor as reduces involved in species-selective binding to SR 48968.
    Wu LH; Vartanian MA; Oxender DL; Chung FZ
    Biochem Biophys Res Commun; 1994 Feb; 198(3):961-6. PubMed ID: 8117303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801.
    Beaujouan JC; Saffroy M; Torrens Y; Glowinski J
    Eur J Pharmacol; 1997 Jan; 319(2-3):307-16. PubMed ID: 9042606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
    Meini S; Catalani C; Bellucci F; Cucchi P; Giuliani S; Zappitelli S; Rotondaro L; Pasqui F; Guidi A; Altamura M; Giolitti A; Maggi CA
    Eur J Pharmacol; 2005 Jun; 516(2):104-11. PubMed ID: 15925360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin3 receptor.
    Chung FZ; Wu LH; Tian Y; Vartanian MA; Lee H; Bikker J; Humblet C; Pritchard MC; Raphy J; Suman-Chauhan N
    Mol Pharmacol; 1995 Oct; 48(4):711-6. PubMed ID: 7476898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of the nonpeptide neurokinin3 (NK3) receptor antagonist, SR142801 on the human NK3 receptor expressed in Chinese hamster ovary cells.
    Oury-Donat F; Carayon P; Thurneyssen O; Pailhon V; Emonds-Alt X; Soubrié P; Le Fur G
    J Pharmacol Exp Ther; 1995 Jul; 274(1):148-54. PubMed ID: 7616392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
    Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
    Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor.
    Goso C; Astolfi M; Parlani M; Manzini S
    Eur J Pharmacol; 1995 Dec; 294(1):239-45. PubMed ID: 8788437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and pharmacological characterization of a functional tachykinin NK3 receptor cloned from the rabbit iris sphincter muscle.
    Medhurst AD; Hirst WD; Jerman JC; Meakin J; Roberts JC; Testa T; Smart D
    Br J Pharmacol; 1999 Oct; 128(3):627-36. PubMed ID: 10516642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors.
    Maggi CA; Astolfi M; Giuliani S; Goso C; Manzini S; Meini S; Patacchini R; Pavone V; Pedone C; Quartara L
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1489-500. PubMed ID: 7996462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
    J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.
    Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G
    Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of tachykinin mediated increases in [Ca2+]i in Chinese hamster ovary cells expressing human tachykinin NK3 receptors.
    Pinnock RD; Suman-Chauhan N; Chung FZ; Webdale L; Madden Z; Hill DR; Woodruff GN
    Eur J Pharmacol; 1994 Sep; 269(1):73-8. PubMed ID: 7530208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GR159897, a potent non-peptide antagonist at tachykinin NK2 receptors.
    Beresford IJ; Sheldrick RL; Ball DI; Turpin MP; Walsh DM; Hawcock AB; Coleman RA; Hagan RM; Tyers MB
    Eur J Pharmacol; 1995 Jan; 272(2-3):241-8. PubMed ID: 7713168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evaluation of alpha and beta human tachykinin NK(2) receptor splice variants expressed in CHO cells.
    Bellucci F; Meini S; Catalioto RM; Catalani C; Giuliani S; Quartara L; Giolitti A; Faiella A; Rotondaro L; Candenas ML; Pinto FM; Maggi CA
    Eur J Pharmacol; 2004 Sep; 499(3):229-38. PubMed ID: 15381044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further identification of neurokinin receptor types and mechanisms of calcium signaling evoked by neurokinins in the murine neuroblastoma C1300 cell line.
    Fukuhara S; Mukai H; Kako K; Nakayama K; Munekata E
    J Neurochem; 1996 Sep; 67(3):1282-92. PubMed ID: 8752137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.